The permanent J-code for ITVISMA® is J3405, and goes into effect starting on July 1, 2026 for all sites of care.
Treatment procedures for ITVISMA
.
Infections
Clinical signs or symptoms of infection should not be evident at the time of ITVISMA administration.1
Single-dose vial
Each carton of ITVISMA contains a single-dose vial with an extractable volume of not less than 3 mL, containing 1.2 × 1014 vg.1
Intrathecal administration
Prior to administration, remove 3 mL of CSF using a lumbar puncture needle. Then administer ITVISMA as an intrathecal bolus injection over approximately 1 to 2 minutes. However, treatment will take longer and sedation or imaging may be needed.1
Learn the steps involved to get your patients treated with ITVISMA
Review key steps before administration and learn about patient management after treatment. Click the sections below for more information.